ESR1 and breast cancer: As a basic predictive marker in endocrine therapy, the effect of PR expression on the prognosis after endocrine therapy has been studied in many cases, such as ER-positive, PR-negative breast cancer has a poor prognosis and is associated with endocrine resistance.